Location of Repository

A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer

By Silverio Tomao, Adriana Romiti, Federica Tomao, Marisa Di Seri, Giuliana Caprio, Gian Paolo Spinelli, Edmondo Terzoli and Luigi Frati
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:1488867
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (1998). A: Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
    2. (1981). A: Reporting results of cancer treatment. Cancer
    3. (2000). Alonso S: Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer:preliminary results of a phase II trial. Semin Oncol
    4. (1999). Arning M: Phase II study of gemcitabine as first line chemotherapy in patients with advanced or metastatic breast cancer. Anticancer drugs
    5. (2000). CC: Single agent gemcitabine as second and third line treatment in metastatic breast cancer. The breast
    6. (1998). EP: New cytotoxic agents and schedules for advanced breast cancer. Semin Oncol
    7. (2003). Gemcitabine plus Paclitaxel:effective and tolerable in interim results of a global phase III study.
    8. (2004). Guillem V: Biweekly paclitexel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain. Ann Oncol
    9. (1993). Hortobagyi GN: The M.D Anderson Cancer center experience with taxol in metastatic breast cancer. Monogragraph Natl Cancer Inst
    10. Mohedano N: Results from a phase II study of gemcitabine in combination with paclitaxel in metastatic breast cancer. Ann Oncol 1998, 9(suppl 4):. abstract 77P
    11. (1995). Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer.
    12. (2001). Phase II trial of the use of paclitaxel and gemcitabine as a salvage treatment in metastatic breast cancer.
    13. (1975). SE: Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer. Cancer
    14. (2001). Single agent gemcitabine is active in previously treated metastatic breast cancer. Oncology
    15. (1993). SR: Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.